Media Release
Aspen Launch Philippines Business
Aspen, Africa’s largest pharmaceutical manufacturer and the biggest listed pharmaceutical group in the health care sector of the Johannesburg Stock Exchange, through Aspen Pharmacare Australia, one of the leading pharmaceutical companies in Australia, aims to make high-quality branded medicine available to Filipino patients at affordable cost through the launch of its local subsidiary, Aspen Philippines.
Read MoreAustralian Packaging Covenant – Aspen Report
The Australian Packaging Covenant is a voluntary initiative by Government and Industry to reduce the environmental effects of packaging. It is designed to minimise the environmental impacts arising from the disposal of used packaging, conserve resources through better design and production processes and facilitate the re-use and recycling of used packaging materials.
Here you can view Aspen Australia’s plan and report.
Read MoreUPDATE: Important Information regarding Di-gesic and Doloxene.
UPDATE: We wish to advise you that the Administrative Appeals Tribunal (AAT) has granted Aspen Australia’s application to stay the cancellation of products containing dextropropoxyphene (Di-Gesic and Doloxene) from the ARTG. This allows us the opportunity to have our appeal of the Therapeutic Goods Administration’s (TGA) decision to cancel the registrations heard by the AAT.
Read MoreSouth China Morning Post Article
In a span of 11 years, Aspen Pharmacare Australia has become one of Australia’s leading pharmaceutical companies, developing a reputation for reliable, regulated and affordable medicines. Aspen-marketed brands account for one out of seven prescriptions written in the country.
Read MoreBusiness Review Australia Article
Aspen Pharmacare Australia Expanding Global Business – from recent acquisition to expansion plans in Asia, Aspen Pharmacare Australia is ready to increase sales and markets.
Read MoreAspen Acquires Sigma’s Pharmaceutical Business For AU$900 Million
Aspen, South Africa’s leading pharmaceutical company, has announced that all conditions precedent have been met for it to acquire the pharmaceutical business of Australian-based Sigma Pharmaceuticals Limited.
Read MoreAspen make a bid for Sigma
Aspen shareholders are advised that Aspen has submitted an indicative non-binding proposal to acquire, either directly or through a wholly-owned subsidiary, Sigma Pharmaceuticals Limited.
Read MoreDiversity and Flexibility eNews
Aspen’s high level of flexibility has shown demonstrable business outcomes in addition to the attraction/retention of diverse talent, including consistently meeting sales objectives and extremely high value customer relationships.
Read MoreAspen take on Tritace and Cardizem
Aspen Pharmacare have signed a licensing agreement with Sanofi-Aventis for the distribution, sales and marketing of Tritace and Cardizem.
Read More